Search Results - "Rivero‐Juárez, A."

Incidence of recently acquired hepatitis C virus infection among HIV‐infected patients in southern Spain by Gonzalez‐Serna, A, Macias, J, Palacios, R, Gómez‐Ayerbe, C, Tellez, F, Rivero‐Juárez, A, Fernandez, M, Santos, J, Real, LM, Gonzalez‐Domenech, CM, Gomez‐Mateos, J, Pineda, JA

“…Objectives Spain is close to HCV microelimination, so rates of recently acquired HCV infection (RAHC) should decrease. Nowadays, men who have sex with men…”
Get full text

Liver Stiffness at the Time of Sustained Virological Response Predicts the Clinical Outcome in People Living With Human Immunodeficiency Virus and Hepatitis C Virus With Advanced Fibrosis Treated With Direct-acting Antivirals by Corma-Gómez, A, Macías, J, Téllez, F, Freyre-Carrillo, C, Morano, L, Rivero-Juárez, A, Ríos, M J, Alados, J C, Vera-Méndez, F J, Merchante, N, Palacios, R, Granados, R, Merino, D, De Los Santos, I, Pineda, J A

“…Abstract Background Some people living with hepatitis C virus (HCV) with sustained virological response (SVR) develop hepatic complications. Liver stiffness…”
Get full text

Association of complement receptor 2 polymorphisms with innate resistance to HIV-1 infection by Herrero, R, Real, L M, Rivero-Juárez, A, Pineda, J A, Camacho, Á, Macías, J, Laplana, M, Konieczny, P, Márquez, F J, Souto, J C, Soria, J M, Saulle, I, Lo Caputo, S, Biasin, M, Rivero, A, Fibla, J, Caruz, A

“…HIV-1 induces activation of complement through the classical and lectin pathways. However, the virus incorporates several membrane-bound or soluble regulators…”
Get full text

HLA-B18 as a risk factor of short-term progression to severe liver fibrosis in HIV/HCV co-infected patients with absent or minimal fibrosis: implications for timing of therapy by Frías, M, Rodríguez-Cano, D, Cuenca-López, F, Macías, J, Gordon, A, Manzanares-Martín, B, Pineda, J A, Camacho, Á, Torre-Cisneros, J, Peña, J, Rivero-Juárez, A, Rivero, A

“…Our aim was to analyze the influence of HLA-B haplotypes on liver fibrosis progression in HIV/hepatitis C virus (HCV) co-infected patients. Retrospective…”
Get full text

HLA-B18 as risk factor of liver fibrosis progression in HIV/HCV treatment-experienced patients by Frías, M, Rodríguez-Cano, D, Cuenca-López, F, Macías, J, Gordon, A, Manzanares-Martín, B, Pineda, J A, Camacho, Á, Torre-Cisneros, J, Peña, J, Rivero-Juárez, A, Rivero, A

Get full text

Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia by Mira, J. A., Neukam, K., López-Cortés, L. F., Rivero-Juárez, A., Téllez, F., Girón-González, J. A., de los Santos-Gil, I., Ojeda-Burgos, G., Merino, D., Ríos-Villegas, M. J., Collado, A., Torres-Cornejo, A., Macías, J., Rivero, A., Pérez-Pérez, M., Pineda, J. A.

“…The aim of this study was to assess the efficacy of and the risk of major bleeding during pegylated interferon (peg-IFN)/ribavirin (RBV) treatment among human…”
Get full text

Familial Hepatitis E Outbreak Linked to Wild Boar Meat Consumption by Rivero‐Juarez, A., Frias, M., Martinez‐Peinado, A., Risalde, M. A., Rodriguez‐Cano, D., Camacho, A., García‐Bocanegra, I., Cuenca‐Lopez, F., Gomez‐Villamandos, J. C., Rivero, A.

“…Summary An HIV‐infected patient was diagnosed with acute hepatitis E infection in our hospital. An epidemiological inquiry was performed to collect…”
Get full text

Screening for hepatitis E virus genotype 3 in red deer (Cervus elaphus) and fallow deer (Dama dama), Portugal, 2018–2020 by Moraes, DFdSD, Lopez‐Lopez, P, Palmeira, JD, Torres, RT, Rivero‐Juarez, A, Dutra, V, Nascimento, MSJ, Mesquita, JR

“…Hepatitis E virus (HEV) genotype 3 is the most prevalent HEV genotype in Europe causing mostly asymptomatic infections in humans, but can also sporadically…”
Get full text

Changes in liver steatosis evaluated by transient elastography with the controlled attenuation parameter in HIV‐infected patients by Macías, J, Real, LM, Rivero‐Juárez, A, Merchante, N, Camacho, A, Neukam, K, Rivero, A, Mancebo, M, Pineda, JA

“…Objectives There are scant data on the progression of hepatic steatosis (HS) in HIV infection. We therefore evaluated changes in HS over time in HIV‐infected…”
Get full text

Bacterial translocation and clinical progression of HCV‐related cirrhosis in HIV‐infected patients by Merchante, N., Aldámiz‐Echevarría, T., García‐Álvarez, M., Rivero‐Juárez, A., Macías, J., Miralles, P., Jiménez‐Sousa, M. A., Mancebo, M., Pérez‐Latorre, L., Pineda‐Tenor, D., Berenguer, J., Resino, S., Pineda, J. A.

“…Summary The aim of the study was to evaluate whether bacterial translocation (BT) predicts the clinical outcome in HIV/HCV‐coinfected patients with compensated…”
Get full text

Parenteral drug use as the main barrier to hepatitis C treatment uptake in HIV‐infected patients by Rivero‐Juarez, A, Tellez, F, Castaño‐Carracedo, M, Merino, D, Espinosa, N, Santos, J, Macias, J, Paniagua‐García, M, Zapata‐Lopez, A, Collado, A, Gómez‐Vidal, MA, Perez‐Stachowski, J, Muñoz‐Medina, L, Fernandez‐Fuertes, E, Rivero, A

“…Objectives Our objective was to identify patient factors associated with being untreated for hepatitis C virus (HCV) infection in HIV‐coinfected patients…”
Get full text

Detection of hepatitis E virus RNA in saliva for diagnosis of acute infection by Rivero‐Juarez, A., Frias, M., Lopez‐Lopez, P., Martinez‐Peinado, A., Risalde, M. Á., Brieva, T., Machuca, I., Camacho, Á., García‐Bocanegra, I., Gomez‐Villamandos, J. C., Rivero, A.

“…Summary Diagnosis of acute hepatitis E virus (HEV) infection is established by detection of anti‐HEV IgM antibodies by ELISA or by amplification of serum viral…”
Get full text

Efficacy of therapy against chronic hepatitis C virus genotype 1 infection in HIV-coinfected patients with several interferon-free DAA combinations: real life data from the HEPAVIR-DAA Cohort by Neukam, K, Téllez, F, Morano-Amado, L.E, Rivero-Juárez, A, Nuño-Álvarez, E, Ríos, M.J, Macías, J, Merino, D, Pérez-Pérez, M, Pineda, J.A

Get full text

Liver stiffness predicts the response to direct-acting antiviral-based therapy against chronic hepatitis C in cirrhotic patients by Neukam, K., Morano-Amado, L. E., Rivero-Juárez, A., Macías, J., Granados, R., Romero-Palacios, A., Márquez, M., Merino, D., Ortega, E., Alados-Arboledas, J. C., Cucurull, J., Omar, M., Ryan-Murua, P., Pineda, J. A.

“…The purpose of this investigation was to evaluate the impact of liver stiffness (LS) on the response to direct-acting antiviral (DAA)-based therapy against…”
Get full text

HIV Coinfection Impairs Response to DAA-Based HCV Therapy by Neukam, K, Suárez-Santamaría, M, Rivero-Juárez, A, Romero-Palacios, A, Ortega, E, de los Santos-Gil, I, Cucurull, J, Vera-Méndez, F, Pineda, J.A

Get full text

Association of low-density lipoprotein receptor genotypes with hepatitis C viral load by Caruz, A, Neukam, K, Rivero-Juárez, A, Herrero, R, Real, L M, Camacho, Á, Barreiro, P, Labarga, P, Rivero, A, Pineda, J A

“…Several data suggest that low-density lipoprotein receptor (LDLR) is a co-receptor for hepatitis C virus (HCV). Soluble LDLR can inhibit HCV infectivity;…”
Get full text

Rural habitat as risk factor for hepatitis E virus seroconversion in HIV‐infected patients: A prospective longitudinal study by Rivero‐Juarez, A., Cuenca‐Lopez, F., Martinez‐Peinado, A., Camacho, A., Real, L. M., Frias, M., Gordon, A., Cantisán, S., Torre‐Cisneros, J., Pineda, J. A., Rivero, A.

“…Summary Our objective was to determine the incidence and clinical manifestations of acute hepatitis E virus (HEV) in HIV‐infected patients. A prospective…”
Get full text

Impact of HIV infection on sustained virological response to treatment against hepatitis C virus with pegylated interferon plus ribavirin by Monje-Agudo, P., Castro-Iglesias, A., Rivero-Juárez, A., Martínez-Marcos, F., Ortega-González, E., Real, L. M., Pernas, B., Merchante, N., Cid, P., Macías, J., Merino, M. D., Rivero, A., Mena, A., Neukam, K., Pineda, J. A.

“…It is commonly accepted that human immunodeficiency (HIV) coinfection negatively impacts on the rates of sustained virological response (SVR) to therapy with…”
Get full text

4CPS-267 Lack of hepatitis C virus uptake in HIV/HCV co-infected patients by Brieva Herrero, MT, Reyes Torres, I, Sáez-Torres de Vicente, M, López López, P, Frias Casas, M, Rivero Juárez, A

“…BackgroundStrategic plans have been developed to eradicate HCV worldwide.Understanding patient factors associated with being untreated for HCV would help in…”
Get full text

Fat mass and obesity‐associated gene variations are related to fatty liver disease in HIV‐infected patients by Núñez‐Torres, R, Macías, J, Rivero‐Juarez, A, Neukam, K, Merino, D, Téllez, F, Merchante, N, Gómez‐Mateos, J, Rivero, A, Pineda, JA, Real, LM

“…Objectives Fatty liver disease (FLD) is frequently observed in HIV‐infected patients. Obesity and type 2 diabetes mellitus (T2DM) are strongly associated with…”
Get full text